title: Interim guidance on the eosinophilia-myalgia syndrome.
authors: Centers for Disease Control, Atlanta, Georgia.
authors: E M
authors: EM
authors: Kilbourne
authors: L A
authors: LA
authors: Swygert
authors: R M
authors: RM
authors: Philen
authors: R K
authors: RK
authors: Sun
authors: S B
authors: SB
authors: Auerbach
authors: L
authors: L
authors: Miller
authors: D E
authors: DE
authors: Nelson
authors: H
authors: H
authors: Falk
mesh_terms: D002487:Centers for Disease Control and Prevention, U.S.; D004802:Eosinophilia / Q000139:chemically induced* / Q000175:diagnosis / Q000628:therapy; D005221:Fatigue / Q000139:chemically induced; D006801:Humans; D009135:Muscular Diseases / Q000139:chemically induced* / Q000175:diagnosis / Q000628:therapy; D010146:Pain / Q000139:chemically induced; D013577:Syndrome; D014364:Tryptophan / Q000009:adverse effects*; D014481:United States
chemical_list: D014364:Tryptophan